TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel SarcopeniaFrailty Treatment at Prestigious International Conference
TNFA Stock | 1.29 0.07 5.15% |
About 62% of TNF Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading TNF Pharmaceuticals, stock suggests that many investors are alarmed at this time. The current market sentiment, together with TNF Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use TNF Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
TNF |
BALTIMORE, December 09, 2024--TNF Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that significant positive topline results from a Phase 2a study of its lead drug candidate MYMD-1 was presented at a prestigious international congress of global experts in sarcopenia and related disorders held December 68, 2024 in Washi
Read at finance.yahoo.com
TNF Pharmaceuticals, Fundamental Analysis
We analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
TNF Pharmaceuticals, is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
TNF Pharmaceuticals, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TNF Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics with similar companies.
Peers
TNF Pharmaceuticals, Related Equities
GLUE | Monte Rosa | 3.03 | ||||
EPIX | ESSA Pharma | 1.87 | ||||
NUVB | Nuvation Bio | 1.49 | ||||
ORIC | Oric Pharmaceuticals | 1.46 | ||||
SNSE | Sensei Biotherapeutics | 0.44 | ||||
DSGN | Design Therapeutics | 0.64 | ||||
INBX | Inhibrx | 0.89 | ||||
ERAS | Erasca | 2.36 | ||||
LYRA | Lyra Therapeutics | 2.83 | ||||
NXTC | NextCure | 2.99 |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |